Dr. Agudelo received his medical degree at the National Autonomous University of Honduras. He completed both his Internal Medicine Residency and Infectious Diseases Fellowship at the University of Oklahoma Health Sciences Center. He is currently the Program Director of the Infectious Diseases Fellowship Program, Medical Lead of the Infective Endocarditis Clinic and the University of Oklahoma Center for Travel and Immigrant Health. He has special interest in reducing healthcare disparities in structurally vulnerable populations.
Academic Section(s):
Infectious Diseases
Education:
Medical School - MD: Universidad Nacional Autónoma de Honduras
Board Certification(s):
Internal Medicine
Infectious Diseases
Residency:
Internal Medicine: University of Oklahoma Health Science Center
Fellowship:
Infectious Diseases: University of Oklahoma Health Science Center
Diploma in Tropical Medicine and Hygiene – Royal College of Physician of London
Memberships:
Infectious Diseases Society of America
American Society of Tropical Medicine and Hygiene
International Society of Travel Medicine
Sociedad Hondureña de Enfermedades Infecciosas
Instituto de Enfermedades Infecciosas y Parasitología Antonio Vida, Honduras
Clinical/Research Interests:
Reduction of Healthcare Disparities
Travel and Tropical Medicine
Immunocompromised Populations
Infective Endocarditis
Select Publications:
Migrants in transit across Central America and the potential spread of chloroquine resistant malaria–a call for action. The Lancet Regional Health - Americas 2023;22: 100505
Health inequities in the global response to the COVID-19 pandemic. Ther Adv Infect Dis. 2023 Apr 10;10:20499361231162726. doi: 10.1177/20499361231162726. eCollection 2023 Jan-Dec.
Burden of serious fungal infections in Honduras. Mycoses. 2022 Apr;65(4):429-439. doi: 10.1111/myc.13432. Epub 2022 Feb 23
Chagas Disease and Domestic Medical Screening Guidance for Newly Arrived Individuals Under a Humanitarian-Based Immigration Status: A Call for Action. Am J Trop Med Hyg. 2022 Nov 14;107(5):960-963
Evaluation of I-TAC as a potential early plasma marker to differentiate between critical and non-critical COVID-19. Cell Stress. 2021 Dec 21;6(1):6-16.
Immunophenotyping assessment in a COVID-19 cohort (IMPACC): A prospective longitudinal study. Sci Immunol. 2021 Aug 10;6(62):eabf3733.
Mortality risk in chronic Chagas cardiomyopathy: a systematic review and meta-analysis. ESC Heart Fail. 2021 Dec;8(6):5466-5481.
Phenotypes of disease severity in a cohort of hospitalized COVID-19 patients: Results from the IMPACC study. EBioMedicine. 2022 Sep;83:104208
Chronic Chagas Disease-the Potential Role of Reinfections in Cardiomyopathy Pathogenesis. Curr Heart Fail Rep. 2022 Oct;19(5):279-289
Chagas disease in Oklahoma. Am J Med Sci. 2022 Nov;364(5):521-528
Rapid health evaluation in migrant peoples in transit through Darien, Panama: protocol for a multimethod qualitative and quantitative study. Ther Adv Infect Dis. 2021 Dec 15;8:20499361211066190